Comparative genomics and transcriptional profiles of Saccharopolyspora erythraea NRRL 2338 and a classically improved erythromycin over-producing strain by Peano, C et al.
RESEARCH Open Access
Comparative genomics and transcriptional
profiles of Saccharopolyspora erythraea NRRL
2338 and a classically improved erythromycin
over-producing strain
Clelia Peano1, Adelfia Talà2, Giorgio Corti1, Daniela Pasanisi2, Miriana Durante3, Giovanni Mita3, Silvio Bicciato4,
Gianluca De Bellis1* and Pietro Alifano2*
Abstract
Background: The molecular mechanisms altered by the traditional mutation and screening approach during the
improvement of antibiotic-producing microorganisms are still poorly understood although this information is
essential to design rational strategies for industrial strain improvement. In this study, we applied comparative
genomics to identify all genetic changes occurring during the development of an erythromycin overproducer
obtained using the traditional mutate-and- screen method.
Results: Compared with the parental Saccharopolyspora erythraea NRRL 2338, the genome of the overproducing
strain presents 117 deletion, 78 insertion and 12 transposition sites, with 71 insertion/deletion sites mapping within
coding sequences (CDSs) and generating frame-shift mutations. Single nucleotide variations are present in 144
CDSs. Overall, the genomic variations affect 227 proteins of the overproducing strain and a considerable number of
mutations alter genes of key enzymes in the central carbon and nitrogen metabolism and in the biosynthesis of
secondary metabolites, resulting in the redirection of common precursors toward erythromycin biosynthesis.
Interestingly, several mutations inactivate genes coding for proteins that play fundamental roles in basic
transcription and translation machineries including the transcription anti-termination factor NusB and the
transcription elongation factor Efp. These mutations, along with those affecting genes coding for pleiotropic or
pathway-specific regulators, affect global expression profile as demonstrated by a comparative analysis of the
parental and overproducer expression profiles. Genomic data, finally, suggest that the mutate-and-screen process
might have been accelerated by mutations in DNA repair genes.
Conclusions: This study helps to clarify the mechanisms underlying antibiotic overproduction providing valuable
information about new possible molecular targets for rationale strain improvement.
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Background
Actinomycetes are ecologically important microorgan-
isms that hold a prominent position in the industry due
to their ability to produce a wide range of secondary
metabolites with biological activities including antibio-
tics, anti-tumour agents and immuno-suppressants [1].
However, these microorganisms must often be geneti-
cally improved for higher production before they can be
used in an industrial setting. Historically, strain
improvement has been empirically carried out by multi-
ple rounds of random mutagenesis and screening [2].
Since the late 1970s, the availability of molecular genet-
ics tools and information about the biosynthetic path-
ways and genetic control for most of secondary
metabolites of commercial interest has opened the way
for improving strains through engineering-based
approaches [3,4]. More recently, these rational strain
improvement strategies benefit from the support of
genomic, transcriptomic, proteomic, and metabolomic
technologies [5-12]. Combining classical and recombi-
nant strain improvement with a solid fermentation
development program represents the optimal synergy to
design commercially successful processes.
The erythromycin fermentation has been improved by
the traditional mutate-and-screen method over the past
50 years. Erythromycin biosynthesis in the mycelial acti-
nomycete, Saccharopolyspora erythraea, has been widely
studied as a model system for antibiotic production
[13-16] and erythromycin and its semi-synthetic deriva-
tives are widely used in the clinic. As such, the develop-
ment of improved producers still represents a
challenging and up- to-date issue. Erythromycin A is
obtained through a three-stage pathway [17], i.e., i)
assembly of the 14-membered macrolactone 6-deoxyery-
thronolide B (6DEB) from one propionyl-CoA and six
(2S)-methylmalonyl-CoA units by multifunctional mod-
ular polyketide synthase followed by ii) its hydroxylation
to erythronolide B (EB), formation of the deoxysugars
mycarose and desosamine from glucose and their addi-
tion to EB to make erythromycin D, and then iii) C-12
hydroxylation and C-3” O-methylation of the latter
compound to produce erythromycin A [18,19].
Extensive genetic studies have provided some insight
into the genes involved in erythromycin biosynthesis
[20,21]. The erythromycin gene cluster contains 20
genes arranged in four major polycistronic units [22].
Evidence for regulatory genes has been missing for a
long time hampering efforts to enhance erythromycin
production other than by medium manipulation, ran-
dom mutagenesis and selection. In recent times, the
availability of the entire genome sequence of S. ery-
thraea and the advent of metabolic engineering opened
the possibility to deeply investigate the molecular
mechanisms controlling erythromycin production
[23-25]. Whole-genome approaches led, for instance, to
the identification of BldD, a key developmental regulator
in actinomycetes [26,27], as one of the major regulators
of erythromycin synthesis [28]. At the same time, meta-
bolic engineering evidenced that, manipulating the
methylmalonyl-CoA metabolite node in S. erythraea and
in Aeromicrobium erythreum, a non-filamentous ery-
thromycin A producer [29,30], i.e., increasing the flux
through feeder metabolic pathways, strongly influences
the erythromycin yields.
Lately, new global approaches based on “RNA poly-
merase and ribosome engineering” have been successful
used to improve erythromycin production under labora-
tory conditions. It has been shown that several muta-
tions affecting rpsL (coding for the ribosomal protein
S12) result in a marked enhancement of erythromycin
production, accompanied by increased transcription of
bldD [31]. It has been reported also that several muta-
tions in rpoB (coding for the beta subunit of RNA poly-
merase) deeply change the transcriptional profile of S.
erythraea. In particular, the expression of genes coding
for key enzymes of carbon (and energy) and nitrogen
central metabolism is dramatically altered affecting in
turn the flux of metabolites through erythromycin fee-
der pathways [32]. Mutations in ribosomal protein- and
RNA polymerase subunit-encoding genes can be easily
selected in the presence of drugs opening the way for a
new approach to strain improvement. Very recently,
complete biosynthesis of erythromycin A and designed
analogs has been obtained using E. coli as a heterolo-
gous host suggesting alternative strategies to improve
erythromycin production [33].
The focus of the present study is to investigate the
molecular mechanisms leading to erythromycin over-
production in a classically improved strain by using a
genomic approach. To this purpose, we identified all
genetic changes that occurred in S. erythraea NRRL
2338/Px (hereafter indicated as S. erythraea Px), an ery-
thromycin overproducer obtained through the traditional
mutate-and-screen method. Compared with parental S.
erythraea NRRL 2338, a total of 117 deletion sites, 78
insertion sites and 12 transposition sites were found
across the genome of the overproducer. Moreover, single
nucleotide variations affecting a total of 144 CDSs were
identified between the two genomes. All genetic changes
have been carefully mapped in S. erythraea Px genome
and genomic information has been used to elucidate the
molecular mechanism underlying the overproduction of
erythromycin by this strain. Genomic comparison has
been supported by comparative transcriptome, an
approach that has been also successful used before this
study [34], and phenotypic analysis.
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Results and discussion
Genomic comparison of S. Erythraea px and S. Erythraea
NRRL 2338
Phenotypic differences between S. erythraea Px and the
reference strain NRRL 2338 are shown in Figure 1.
With respect to NRRL 2338, Px exhibited slower growth
and reduced sporulation in both Yeast Starch (YS) and
Oatmeal Yeast (OMY) agar plates, less pigmentation in
OMY agar, while the phenotypes of the two strains were
more similar in Soluble Complete Medium (SCM) agar.
SCM broth was used in fermentation and microarray
experiments (see below).
To understand the genetic bases underlying phenoty-
pic differences between the two strains and improved
erythromycin A production in Px, whole genome of this
strain was sequenced and compared with that of NRRL
2338. The genome of Px consists of a single circular
chromosome of 8,212,111 bp with an average G + C
content of 71.14%. The size of the Px chromosome is
694 bp smaller than that of NRRL 2338. Genomic com-
parison revealed highly conserved gene content and
gene order between these two strains (Figure 2A). The
two genomes are 99.1% identical and there is no
remarkable change in the chromosome structure as
clearly shown in the dot-plot comparison.
Compared with NRRL 2338, a total of 117 deletion sites,
78 insertion sites and 12 transposition sites were found
across the Px genome. Among them, 71 sites are single
nucleotide insertions/deletions (indels), which affect coding
sequences leading to frame-shift mutations, and only 11 are
indels larger than 100 bp. The largest insertion is 1127 bp
near position 5,393,000 which is located between an oxi-
doreductase (SACE_4827) and a transcriptional regulator
(SACE_4828), while the largest deletion is 1147 bp in
6,849,979-6,851,124 (corresponding to SACE_6108, an
ATP-dependent helicase) which is located between a
methyltransferase (SACE_6107) and a glycosyl transferase
(SACE_6109)
Apart from frame-shift mutations, single nucleotide var-
iations (SNVs) affecting a total of 144 CDSs were identified
between the two chromosomes. The SNVs generate 110
missense and 10 nonsense mutations. The variations, also
including 4 CDS duplications, 7 transposon/transposable
element insertions and 1 transposon excision, affect a total
of 227 proteins in the Px genome. Chromosome map of
genetic variations distinguishing Px from NRRL 2338 is
shown in Figure 2B. Mutations are homogeneously scat-
tered along the whole chromosome without “core genome”
vs. “non-core genome” preference. The mutated CDSs, the
corresponding gene/locus names, the nature of variations
Figure 1 Phenotypes of S. erythraea NRRL 2338 and S. erythraea Px cultivated on agar media. Strains were cultivated for 7 days on YS,
OMY or SCM agar plates as shown. Bottom (upper panel) and top (lower panel) sides of the agar plates were photographed.
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and presumed functions are reported in Tables 1, 2, 3, 4, 5,
6 with reference to the following aspects: i.) carbon, nitro-
gen and sulfur metabolism; ii.) substrate uptake, membrane
permeability and secretion; iii.) biosynthesis of secondary
metabolites; iv.) transcription and translation processes; v.)
cell division, DNA replication and repair, transposition and
phage integration; vi.) CDSs of unknown functions.
Transcriptome comparison of S. Erythraea px and S.
Erythraea NRRL 2338
To gain further insight about the molecular mechanisms
underlying improved erythromycin A production in Px
strain, DNA microarray of S. erythraea were manufac-
tured and used for comparative analysis between Px and
NRRL 2338. Microarray data for NRRL 2338 strains
were already available [24]. In DNA microarray experi-
ments Px and NRRL were cultivated under standard
batch-culture conditions in SCM broth [29] and ery-
thromycin production was evaluated at different time
points (Figure 3).
Due to the different length of lag phase, RNA samples
were collected during growth of NRRL 2338 in the time
interval 12-72 h, and in the time interval 24-84 for Px.
Despite similar final values of biomass, shapes of growth
Figure 2 Dot plot and chromosome map of genetic variations distinguishing S. erythraea Px from S. erythraea NRRL 2338. A) Dot plot
comparison beetwen the S. erythraea NRRL 2338 and Px strains generated by MUMmer software. B) Chromosome map of genetic variations
distinguishing Px from NRRL 2338. The outer scale is numbered in megabases starting from the origin of replication (OriC), and indicates the
core (blue) and noncore (yellow) regions. Outer circle: S. erythraea NRRL 2338 genescolor-coded by their COG function (orange, cellular process
and signaling; purple, information storage and processing; light blue, metabolism; pale green, poorly characterized); inner circle: positions of
variations between Px and NRRL 2338 color-coded by type (green, frameshift; purple, nonsense; yellow, missense). Position of secondary
metabolism cluster genes are shown.
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Table 1 Variations within genes related to central carbon, nitrogen and sulfur metabolism
Gene locus in
NRRL 2338
Length
(amino
acids)
Gene/
locus
Variationa Protein function and notes
Central carbon and energy metabolism
SACE_0618 286 ccdA Missense (G38S) Cytochrome c biogenesis protein
SACE_0633 221 citA IPM Citrate synthase (N-terminal)
SACE_1638 609 sucB Missense (V574A) 2-oxoglutarate dehydrogenase complex E2 component
(dihydrolipoamide succinyltransferase)
SACE_3073 375 hypD Nonsense (Y30*) Hydrogenase expression/formation protein HypD
SACE_5291 335 dhaK Frameshift (-C 717) Dihydroxyacetone kinase N-terminal containing protein (DhaK)
SACE_6118 1125 pyc Frameshift (-C 1222) Pyruvate carboxylase
SACE_6385 1206 kgd
(sucA)
Missense (1773 S) 2-oxoglutarate dehydrogenase complex El component
SACE_6668 288 sucD In frame insertion (-2081, -209V,
-210M, -2111, -212G, -213E)
Succinyl-CoA synthetase, alpha subunit
Nitrogen and amino acid
metabolism
SACE_0635 122 ureB Frameshift (-C 352) Urease beta subunit
SACE_3800 689 Missense (P601L) Assimilatory nitrate reductase catalytic subunit (selenocysteine-
containing)
SACE_4319 426 aspB Missense (Y185C) Aspartate aminotransferase
SACE_5299 433 Missense (G103R) D-amino acid deaminase
SACE_5427 417 Frameshift D-amino acid dehydrogenase, small
SACE_5741 500 gltD Frameshift (-G 1301) Glutamate synthase NADH/NADPH, small subunit
SACE_6330 421 Frameshift (-G 324) Fusion protein (ligase/carboxylase and argininosuccinate lyase)
SACE_6764 378 Missense (T47A) Frameshift (-C 436) Alanine racemase
Sulfur and amino acid metabolism
SACE_3346 517 Missense (C286R) Sulfite oxidase/oxidoreductase, molybdopterin binding
SACE_4434 269 tauC Missense (L221F) Taurine transport system permease protein TauC
SACE_4651 279 tauD Missense (G177S) Taurine dioxygenase, 2-oxoglutarate-dependent
SACE_6133 158 cdo2 Missense (P151S) Cysteine dioxygenase
Sugar
metabolism
SACE_0652 383 iroB Missense (A325V) Glycosyl transferase, related to UDP-glucuronosy transferase
SACE_1940 788 lacZ2 Missense (A769V) Beta-galactosidase/beta-glucuronidase
SACE_3069 207 gmhA Frameshift (-G 429) Phosphoheptose isomerase
SACE_3071 223 gmhA Frameshift (-C 75,-C 90, -C91, -T 95,
-G 98, -G 99, -C 100, -G 126)
Phosphoheptose isomerase
SACE_3737 1001 ama2 Missenses (R121A,N122Q, T123A,
F124L, I125H, V127R)
Alpha-mannosidase
SACE_4596 814 Missense (L810Q) Beta-galactosidase/beta-glucuronidase
SACE_5147 1099 embC Nonsense (S399*) Arabinosyl transferase
SACE_5208 1098 embC Missense (S799F) Arabinosyl transferase
SACE_5734 657 Frameshift (+A 1027/1028) Galactofuranosyl transferase
SACE_6416 201 rmlC Missense (A173T) dTDP-4-dehydrorhamnose 3,5-epimerase
SACE_6564 328 deoC Missense (G16S) Deoxyribose-phosphate aldolase
SACE_6765 501 Missense (R207G, P208R) Ribokinase
SACE_6971 433 Missense (S23F) Glycosyl transferase
Fatty acid
metabolism
SACE_0351 281 estC Missense (A211T) Esterase
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and erythromycin production curves were markedly dif-
ferent between the two strains. Erythromycin production
by both strains was detectable after 12 h. Consistently
with previous findings [24], three distinct phases could
be distinguished during erythromycin fermentation in
the reference strain: an initial period of rapid increase of
antibiotic concentration lasting until 60 h (phase a), fol-
lowed by a period of production slowdown until 72 h
(phase b), and a second period of moderate increase of
erythromycin titers from 72 to 84 h (phase c) before
entering the stationary phase. In the erythromycin
overproducer phase a was protracted longer up to 72 h,
phase b lasted until 84 h, while phase c was character-
ized by gradual increase of erythromycin titers until 108
h with a further period of production slowdown
between 108 and 120 h followed by a further increase
up to 132. Therefore, while during growth of NRRL
2338 erythromycin titers remained stable over the sta-
tionary phase, during growth of Px the antibiotic con-
centration continued to increase in the exhausted
medium after entering the stationary phase reaching
final titers about five-fold higher than in NRRL 2338.
Table 1 Variations within genes related to central carbon, nitrogen and sulfur metabolism (Continued)
SACE_3132 275 abmC Missense (V246G) Frameshift (-C
742)
Enoyl-CoA hydratase/isomerase (rev hydr) Putative: 2-
ketocyclohexanecarboxyl- CoA hydrolase (amino benzoate
degradation)
SACE_3216 526 Frameshift (-G 1366) Long-chain acyl-CoA synthetase
SACE_3361 329 Missense (T312I) Glycerophosphoryl diester phosphodiesterase
SACE_3450 304 IPM Enoyl-CoA hydratase/isomerase
SACE_3478 568 IPM Long-chain acyl-CoA synthetase
SACE_3745 255 Missense (L187R) Enoyl-CoA hydratase/isomerase
SACE_3936 246 Missense (L48H) 3-oxoacyl-[acyl-carrier protein] reductase
SACE_4589 388 Frameshift (+CACC 10/11) Acyl-CoA dehydrogenase
Nucleotide
metabolism
SACE_1282 360 nrdB Missense (S2N) Ribonucleotide-diphosphate reductase subunit b
SACE_2080 432 pyrC Missense (A90V) Dihydroorotase
SACE_6664 521 purH Missense (P54S) Bifunctional phosphoribosylaminoimidazolecarboxa mide
formyltransferase/IMP cyclohydrolase No paralogue.
SACE_7125 538 purF Missense (P497S) Glutamine phosphoribosylpyrophosphate amidotransferase No
paralogue
SACE_2398 165 prsA Missense (T123P) Phosphoribosylpyrophosphate synthetase
SACE_5196 506 codA Missense (Y322S) Cytosine deaminase
Vitamin and cofactor metabolism
SACE_0506 376 thiO Missense (A44V) Amino acid oxidase flavoprotein ThiO, putativeGlycine/D-amino acid
oxidases
SACE_0511 547 thiC Missense (T30I) Thiamine biosynthesis protein ThiC
SACE_5955 1201 cobN Missense (A1091T) Cobaltochelatase subunit CobN
Monooxygenases/oxidoreductases/methyltransferases/hydrolases of unknown function
SACE_0651 422 cypA Frameshift (+C 16/17; +C 22/23) Cytochrome P450
SACE_0781 191 Missense (P80S) NADPH-dependent FMN reductase
SACE_4325 341 Frameshift (-C 890) Radical SAM family protein Fe-S oxidoreductase
SACE_4560 326 Frameshift (+A 58/59) SAM-dependent methyltransferase
SACE_4563 515 Missense (S9F) Coproporphyrinogen III oxidase
SACE_4854 366 Frameshift (+G 477/478) Amine oxidase, flavin-containing protein
SACE_5012 454 Missense (G114E) Haem peroxidase
SACE_5030 372 Frameshift (-G 553) Oye family NADH-dependent flavin oxidoreductase
SACE_5053 229 Missense (L204F) Amidohydrolase 2
SACE_6588 491 Frameshift (-C 633) Monooxygenase, FAD-binding
SACE_7243 462 Nonsense (W188*) FAD-dependent oxygenase/FAD/FMN-containing dehydrogenase
aIPM, imperfect match
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Table 2 Variations within genes related to substrate uptake, membrane permeability and secretion
Gene locus
in NRRL
2338
Length
(amino
acids)
Gene/
locus
Variationa Protein function and notes
Transport system
SACE_0429 646 Missense (P416L) ABC-type transport system,
permease component
SACE_0924 482 Frameshift (-C212;-C 221;-C 228; -G 264; -G 273) Extracellular solute binding protein
SACE_0925 337 1PM ABC-type transport system,
permease component
SACE_0926 284 Missense (V18M, A89T) ABC-type sugar transport system,
permease component
SACE_0991 300 Frameshift (-G 370) Dipeptide transport system
permease
SACE_1587 297 Frameshift (-C 585) Sugar transport system permease
SACE_1969 152 Missense (L90R) Twin-arginine translocation
pathway signal
SACE_2131 278 Missense (L275F) Permease of the drug/metabolite
transporter (DMT) superfamily
SACE_2701 276 Frameshift (-C 750) ABC-type transport system, ATP
binding component
SACE_3038 545 Frameshift (+C 1407/1408) ABC-type transport system, ATP
binding component
SACE_3524 489 Frameshift (+G 976/977) Permease of the major facilitator
superfamily
SACE_4034 426 Missense (L221P) Permease of the major facilitator
superfamily
SACE_4066 343 Frameshift (+C 268/269) C4 dicarboxylate transporter/malic
acid transport protein
SACE_4307 309 Missense (A90T) Integral membrane transport
protein
SACE_4347 555 Missense (A277G) Sodium:solute symporter
SACE_4454 466 Missense (G348S) Permease of the major facilitator
superfamily
SACE_4982 407 Missense (L145F) Integral membrane transport
protein
SACE_5435 688 Missense and in frame deletion (N244T, G245A, A246P, D247D, R248A,
L249A, H250R, G251R, G252L, L253T, Q255C, L256A, Q258H, A259R, T260G,
L263-, P264-, T254S)
ABC-type transport system,
permease component
SACE_5787 318 Missense (G300R) Dipeptide ABC transporter, ATP-
binding protein
SACE_6087 200 kdpC IPM Potassium-transporting ATPase, C
chain
SACE_6246 229 Missense (R206C) Phosphoenolpyruvate-protein
phosphotransferase
SACE_6319 455 Frameshift (-C 1095) Permease of the major facilitator
superfamily
SACE_6323 315 Frameshift
(-AT 913 and 914)
Dipeptide/oligopeptide/Nichel ABC
transporter, permease component
SACE_6326 444 Frameshift (-G 1036) Permease of the major facilitator
superfamily
SACE_6578 364 Missense (G270R) ABC-type sugar transport system,
permease component
SACE_6927 392 Missense (P121L) Permease of the drug/metabolite
transporter (DMT) superfamily
SACE_6972 314 Missense (L224F) Permease of the major facilitator
superfamily
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Moreover, while NRRL 2338 produced essentially ery-
thromycin A during fermentation, Px yielded erythromy-
cin A along with significant amounts of its immediate
precursors erythromycin B and erythromycin C (Figure
3).
Gene expression data were analyzed to identify tran-
scripts modulated during the growth curve. Considering
each time point replicate as an independent entry and
setting the confidence threshold at q-value ≤ 0.001 (see
Methods), the EDGE algorithm identified a total of 404
differentially expressed genes (DEGs) in NRRL 2338
(6.22% of total probeset) with 220, 32 and 152 genes
up-regulated, respectively, during phase a, b and c. In
the Px strain the number of DEGs identified increased
to 577 (8.88% of total probeset) and only two clusters of
genes up-regulated, respectively during phases a (459
genes) and phase b (104 genes) could be clearly distin-
guished. Microarray analysis confirmed changes in glo-
bal control of cell cycle in Px strain with respect to
NRRL 2338 (Figure 4).
Inspection of functional classification of cell cycle-
regulated genes showed that the increment in the num-
ber of DEGs in Px was mostly due to genes belonging
to the following clusters of orthologous groups (COGs):
I.5 Intracellular trafficking, secretion, and vescicular
transport; I.6 Posttranslational modification, protein
turnover, chaperones (in the functional category Cellular
processes and signaling); II.12 Translation, ribosomal
structure and biogenesis; III.8 Nucleotide transport and
metabolism; III.9 Posttranslational modification, protein
turnover, chaperones (in the functional category Meta-
bolism) (Table 7). At the same time the following
clusters of orthologous group resulted under-repre-
sented: II.11 Transcription and III.3 Cell wall/mem-
brane/envelope biogenesis. In Table 7 the COGs have
been considered over- represented (bold numbers in
Table 7) if the percentage of the genes belonging to
each category respect to the total of DEGs resulted 2
times more than the percentage of the genes belonging
to each category respect to the total of GeneChip probe-
sets. On the contrary they were considered under-repre-
sented (oblique numbers in Table 7) if the percentage of
the genes belonging to each category respect to the total
of DEGs resulted less than half of the percentage of the
genes belonging to each category respect to the total
probesets. A complete list of the cell cycle-regulated
genes in NRRL 2338 and Px is available as supplemental
data files (Additional files 1, 2), while the lists of genes
up-regulated during phase a either in both strains or in
Px or in NRRL 2338 are reported, respectively, in Addi-
tional files 3, 4, 5.
The Locally Adaptive Statistical Procedure (LAP) [35]
of the PREDA package [ref] was used to identify differ-
entially expressed chromosomal regions (Figure 5). LAP
analysis showed significant up-regulation of many genes
clustered in the “core” region of the chromosome
(mostly containing essential genes) in both NRRL 2338
and Px strains during phase a, including the erythromy-
cin biosynthetic cluster (ery) and the ribosomal pro-
teins-encoding operons (Figure 5A and 5B). In contrast
most of genes clustering in the “non-core” region of the
chromosome (mostly containing “contingency” genes)
were down-regulated during this growth phase. The
only notable exception was represented by pks6 cluster
Table 2 Variations within genes related to substrate uptake, membrane permeability and secretion (Continued)
SACE_7047 403 Frameshift (+T 654/655) Major facilitator superfamily sugar
transporter
SACE_7202 327 Frameshift (+C 873/874) Integral membrane transport
protein
Exo-enzymes
SACE_1076 326 chiA2 Nonsense (W315*) Chitinase A
SACE_3366 364 Insertion of SACE-2828 (transposase) Feruloyl esterase
SACE_3961 296 Missense (W21C) Phospholipase D/diacylglycerol
kinase
SACE_6961 263 Frameshift (-C 729) Phospholipase D/diacylglycerol
kinase
Membrane and cell wall structures/enzymes
SACE_1186 202 Frameshift (+C 84/85) Lipoprotein
SACE_2081 178 Missense (G62D) Integral membrane protein
SACE_2338 338 Missense (P299R) Membrane-bound lytic murein
transglycosylase B
SACE_4420 192 Frameshift (-C 79) Lipoprotein
SACE_5285 645 Frameshift (-T 29, +C 1890/1891) Lipoprotein
aIPM, imperfect match
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coding for an unknown type II polyketide [23], which
was up-regulated in Px strain during phase a. Moreover,
while in NRRL 2338 the biosynthetic clusters nrps3,
nrps5, tpc2, tpc3 and tpc4 clearly appeared to be down-
regulated during phase a, in Px only two clusters, tpc4
and tpc5, exhibited this behavior suggesting profound
differences in control of secondary metabolism between
the two strains (Figure 5A and 5B). The LAP analysis
failed to identify regions exhibiting significant differen-
tial gene expression between phase b and phase c in
NRRL 2338 see Peano et al. 2007 [24].
Central carbon and nitrogen metabolism in S. Erythraea
px
Table 1 shows that a considerable number of mutated
genes are involved in central carbon (and energy) and
nitrogen metabolism, or related to substrate uptake and
utilization (Table 2). This is not surprising because ery-
thromycin biosynthesis is strictly connected with central
metabolism consistently with both genomic and expres-
sion data. In general, secondary metabolism is believed
dispensable for survival, and most of gene clusters cod-
ing for secondary metabolites occupy non-core genomic
regions and are maximally expressed during late growth
phases. In contrast, the ery cluster maps in the core
Table 3 Variations within genes related to biosynthesis of secondary metabolites
Gene locus in
NRRL 2338
Length
(amino
acids)
Gene
(locus)
Variationa Protein function and notes
Polyketide synthases and related biosynthetic proteins
SACE_0019 95 (pfa) Nonsense (Q86*) Acyl carrier protein
SACE_0022 752 pfaB
(pfa)
Frameshift (+T
2003/2004)
Modular polyketide synthase (pfa gene cluster) (module 1: KR-ACP)
SACE_0023 2322 pfaC
(pfa)
Missense (A317T,
D1707N)
Modular polyketide synthase (pfa gene cluster) (module 2: KS-TE)
SACE_0718 237 eryCVI
(ery)
Missense (T64A) Erythromycin biosynthesis: TDP-desosamine-N-dimethy transferase
SACE_0720 322 eryBIV
(ery)
Missense (G3E) Erythromycin biosynthesis: dTDP-4-keto-6-deoxy-L-hexose 4-reductase
SACE_2595 2368 Missense (G1215S,
D1118N)
Type I polyketide synthase (module: KS-AT-DH-ER-KR-ACP)
SACE_2630 4576 pks2-l
(pks2)
Missense (A3004V) Modular polyketide synthase (module 1: KS-AT(P)-ACP; module 2: KS-AT(A)-DH-KR-
ACP; module 3: KS-AT(A)-DH-KR-ACP)
SACE_2875 4132 (pks3) Frameshift (-G
2035)
Modular polyketide synthase (pks3 gene cluster (load: CL-ACP; module 1: KS-AT(P)-
DH-ER-KR-ACP; module 2: KS-AT(A)-ACP)
SACE_2876 252 gdmF
(pks3)
Missense (G17W) 3-amino-5-hydroxybenzoic acid synthase (AHBA synthase)
SACE_2888 455 Missense (V91C) Aromatic-L-amino-acid decarboxylase
SACE_4140 3481 pkeA2
(pke)
Missense (F1282V) Modular polyketide synthase (module 1: KS-AT(A)-DH-KR-ACP; module 2: KS-AT(A)-
DH-KR-ACP)
SACE_5308 1730 (pks7) Missense (A795T) Iterative type 1 polyketide synthase
Non-ribosomal peptide synthases and related biosynthetic proteins
SACE_3015 1083 (nrps4) 1PM Non-ribosomal peptide synthase
SACE_3016 334 (nrps4) Missense (V245F) SyrP-like protein
SACE_3033 441 Missense (R186C) Lysine/ornithine N-monooxygenase
SACE_3057 547 Missense (A481T) 2-polyprenyl-6-methoxyphenol hydroxylase
SACE_4288 7259 (nrpsl) Missense (P6258L) Non-ribosomal peptide synthase
Terpene synthases and related biosynthetic proteins
SACE_3187 758 (tpcl/
geol)
Nonsense (W83*) Terpene synthase metal-binding domain-containing protein
SACE_3978 466 (tpc3/
geo2)
Frameshift (+G
1040/1041)
Cyclic nucleotide-binding domain-containing protein (tpc3 gene cluster)
aIPM, imperfect match
Abbreviations: CL thioester ligase; KSQ Initiating decarboxylase; KS ketosynthase; AT acyltransferase (A and P refer to specificity for acetate and propionate units
respectively); ACP acyl carrier protein; KR ketoreductase; TE thioesterase; AMT aminotransferase; P450 cytochrome P450 hydroxylase; DH dehydratase; ER
enoylreductase
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Table 4 Variations within genes related to transcription and translation processes
Gene locus in
NRRL 2338
Length
(amino
acids)
Gene
(locus)
Variationa Protein function and notes
SACE_2076 148 nusB Frameshift
(-G 316)
NusB antiterminator factor No paralogue.
Transcription factors
SACE 0891 206 Frameshift (+G 581/582) TetR family transcriptional regulator
SACE_1040 163 Missense (R30C) MarR family transcriptional regulator
SACE_1895 281 Frameshift (+C 603/604) XRE family transcriptional regulator
SACE_2927 918 Missense (P52L) SARP family transcriptional regulator
SACE_3079 294 Frameshift
(-C 506)
LysR family transcriptional regulator
SACE_3348 96 Missense (E60A) XRE family transcriptional regulator
SACE_4500 233 Frameshift
(-C 129; -G 222)
GntR family transcriptional regulator
SACE_4536 327 Missense (T246N, L249M) Lacl family transcription regulator
SACE_4775 246 Missense (A96V) MerR family transcriptional regulator
SACE_5410 287 Missense (P140F) XRE family transcriptional regulator
SACE_5425 505 Missense and in frame deletion (V297S, V298W, A299R,
V300C, Q301R A302P, H303R, D304-, G305R)
PucR- family transcriptional regulator
SACE_5448-
SACE_5449
126
150
Duplication of SACE_5448 and SACE_5449 SACE_5448: Unknown function SACE 5449: LuxR
family transcriptional regulator
SACE_5739 282 Missense (K206T) XRE family transcriptional regulator
SACE_6021 484 Frameshift (+A 1212/1213) PucR- family transcriptional regulator
Signal transduction
SACE_1833 241 Frameshift (-C 667) Two-component system response regulator
SACE_1879 587 Frameshift (+C 1002/1003) Serine/threonine protein kinase
SACE_1988 150 Missense (G125D) Universal stress protein UspA
SACE_2583 541 Nonsense (R478*) N-acyl D-amino acid deacylase
SACE_4937 414 Missense (G30R) Mandelate racemase/starvation sensing protein
SACE_5284 286 staP IPM Endonuclease/Exonuclease/Phosphatase family
protein
SACE_5286 224 Frameshift (-G419, -G 430) Two-component system response regulator
SACE_5301 533 Frameshift (+C 1585/1586) N-acyl_D-amino acid deacylase
SACE 6086 879 kdpD Missense (P828L) Osmosensitive K+ channel histidine kinase
SACE_6447 228 mtrA In frame deletion (VI96-, HI97-) Two-component system response regulator
SACE_6490 424 Missense
(S37R)
Two-component system sensor kinase
SACE_6720 526 phoD Missense (C328Y, P382F) Phosphodiesterase/alkaline phosphatase D
(phosphate starvation)
SACE_7263 382 Missense (A222T) Two-component system sensor kinase
Translation machinery
SACE_0443 464 cysS Missense (G198S) Cysteinyl-tRNA synthetase
SACE_0799 593 metS Missense (P569S) Methionyl-tRNA synthetase
SACE_2075 188 efp Frameshift (+C 504) Elongation factor P
SACE_3403 474 gatA Missense (A243E) Asp-tRNAAsn/Glu-tRNAGln amidotransferase A
subunit
SACE_5926 1027 infB Missense (A278V) Translation initiation factor 2
SACE_5919 536 Frameshift (-G 821) Pseudouridine synthase
Protein turnover and chaperones
SACE_1339 860 IPM Aminopeptidase N
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region of the S. erythraea chromosome, and is tran-
scribed during the middle pseudo-exponential growth
phase when the activities if the carbon and nitrogen
central metabolic pathways are maximal (Figures 4 and
5) [23,24,32,36].
As shown in Figure 6, these pathways are strictly
connected to erythromycin biosynthesis that requires
one propionyl-CoA and six (2S)-methylmalonyl-CoA
units for assembly of the 14- membered macrolactone
6DEB. Different metabolic routes may accomplish
Table 4 Variations within genes related to transcription and translation processes (Continued)
SACE_2951 174 clpC Frameshift (+G 468/469) ATPases with chaperone activity, ATP-binding
subunit
SACE_3756 768 clpA Missense (I284T) ATPases with chaperone activity, ATP-binding
subunit
SACE_6784 610 Frameshift (-C 1573) Molecular chaperone
SACE_6113 481 IPM? Aminopeptidase
aIPM, imperfect match
Table 5 Variations within genes related to cell division, DNA replication and repair, transposition and phage
integration
Gene locus in
NRRL 2338
Length
(amino
acids)
Gene
(locus)
Variationa Protein function and notes
DNA replication and repair
SACE_0826 1195 mfd Frameshift (+A 218/219) Transcription/repair coupling factor
SACE_1351 269 mutM,
fpg
Missense (M199T) Formamidopyrimidine DNA glycosylase
SACE_3677 147 ogtl Missense (G41K) Methylated DNA-protein cysteine methyltransferase
SACE_4427 183 Frameshift (+G 353/354) G/U mismatch-specific DNA glycosidase
SACE_5437 895 polA Frameshift (-C617) DNA polymerase I
SACE_5255 207 alkA Missense (P68F) 3-methyladenine DNA glycosylase
SACE_6108 693 uvrD2 IPM ATP-dependent DNA helicase UvrD-like
Missense and in
SACE_6681 873 uvrD frame deletion (G54-, G56R, S57I) ATP-dependent DNA helicase UvrD
Cell division
SACE_0667 941 Missense (F874L) DNA segregation ATPase FtsK/SpoIIIE
SACE_6104 263 IPM Cell division initiation protein
SACE_6929 579 Missense (P159R) ATPase involved in chromosome partitioning
Transposition and phage integration
SACE_0657 106 Excision lS1647-like transposase
SACE_2154 350 IPM Transposase, IS891/IS1136/IS1341
SACE_2214and
similar CDSs
365 Insertion between SACE_4827 and
SACE_4228
SACE-2214: Transposase SACE_4827: Oxidoreductase
SACE_4228: LacI family transcriptional regulator
SACE_2313 and
similar CDSs
99 Insertion between SACE_2371 and
SACE_2372
SACE_2313: IS4-like transposase SACE_2371: IS4-like
transposase SACE_2372: IS 1647-like transposase
SACE_2322 374 Missense (VI391) Phage-related integrase/Site-specific recombinase XerC
SACE_3579 469 tnp Missense (R13S, A73S, T118A, V309A) Transposase, 1S1XX5
SACE_4072 469 tnp Missense (S178L, Q191R, S199A,H218R,
N370T, G430S, T431V)
Transposase, ISlxx5
SACE_5073 459 Missense (N171K) Transposase, IS3508i
Missense and in frame insertion
SACE_5268 395 (S73T, A74P, H129N,-134T, -135V,L191V,
I216V A296V, P388R, S396L)
Transposase inactivated by frameshift mutation)
SACE_5430 232 Missense (H15R, R193W) Transposase, Tn5714
aIPM, imperfect match
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Table 6 Variations within genes of unknown function
Gene
locus in
NRRL
2338
Length
(amino
acids)
Gene/
locus
Variationa Protein function and notes
Unknown function
SACE_0062 35 Insertion betweenSACE_ 2351 and SACE_2352 SACE_0062: Unknown function. SACE_2351: Tn5714-
like transposase. SACE_2352: IS 111 a/IS 1328/IS1533-
like transposase.
SACE_0062 35 Insertion in SACE_5430, between SACE_5429 and
SACE_5431
SACE_0062: Unknown function. SACE_5429:
Dephospho-CoA kinase SACE_5430: Transposase,
Tn5714 SACE_5431: 30S ribosomal protein SI
SACE_0157 389 Missense (P295L) Unknown function/Glutathionylspermidine synthase
SACE_0587 995 Frameshift (+G 332/333) Unknown function
SACE_0744 164 Missense (R42H) Unknown function
SACE_0940 289 IPM Unknown function
SACE_0944 831 Nonsense (Y412*) Unknown function
SACE_1128 294 Missense (VI13 A) Unknown function
SACE_1129 774 Missense (A172T) Unknown function
SACE_1257 195 Nonsense (Q60*) Unknown function/uncharacterized MobA-related
protein
SACE_1344 1638 IPM? Unknown function/PE-PGRS family protein
SACE_1805 100 Missense (S13F) Unknown function
SACE_1835 175 IPM Unknown function
SACE_1853 110 Frameshift (+G 51/52) Unknown function
SACE_2384 496 Frameshift (+T 823/824) Unknown function
SACE_2456 251 Missense (A28V) Unknown function
SACE_2737 116 Missense (P4R) Unknown function
SACE_3005 316 Frameshift (-G 727) Unknown function
SACE_3102 1249 Frameshift (+G 338/339) Unknown function
SACE_3186 392 Missense (R390S) Unknown function (tpcl cluster)
SACE_3262 282 Frameshift (+C 434/435) Insertion between Unknown function
SACE 3264: Unknown secreted protein.
SACE_3264 117 SACE 3572 and SACE 3573 SACE 3572: Unknown secreted protein. SACE 3573:
Unknown function
SACE_3748 277 Frameshift (+C 696/697) Unknown function
SACE_3850 261 Frameshift (-G 388) Unknown function
SACE_3925 188 Frameshift (+A 437/438) Unknown function
SACE_4249 234 Frameshift (-G 640) Unknown function
SACE_4310 480 Frameshift
(-C 1146)
Unknown function
SACE_4451 291 In frame insertion (-102D,-103A, -104N,-105E, -106Q) Unknown function
SACE_4989 38 Insertion between SACE_5103 and SACE_5105 SACE_4989: Unknown function. SACE_5103: Type III
restriction enzyme, res subunit.
SACE_5105: Transposase
SACE_5311 835 Missense (G411R) Frameshift Unknown function
SACE_5423 184 (-G 372, -G 473, -C 481,-G 493,-T 409,-C 540) Unknown function
SACE_5446 1184 Frameshift (-C 2898) Unknown function
SACE_5460 330 Missense (P162F) Unknown function
SACE_5482 632 Missense
(L509P)
Unknown function
SACE_5483 11792 Missense (L1329F, T5002A, P8537L, R9518H) Unknown function
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Table 6 Variations within genes of unknown function (Continued)
SACE_5513 566 In frame deletion (S249-, E250-,G251-, T252-,T253-, G254-,
G255-, T256-, G257-, G258-, A259-, G260-)
Unknown function
SACE_5523 5856 Nonsense (L370*) Unknown function
SACE_5655 31 Duplication of SACE_5655 Unknown function
SACE_5905 418 Missense and in frame insertion (A5V, T7G, I8C, R10H, V11H,
Q12L, T13A, M14G, S15A I16D, E17H, S18E, A19H, R21E,
T22R, L24A, -25H, -26R, -27A)
Unknown function
SACE_6184 171 Frameshift (-G 169) Unknown function
SACE_6567 206 Missense, in frame insertion, nonsense (A135G,-136R,- 137R,-
138G,-139A,- 140A,-141R,-142W, -143G,-144P, -145P, -146R,-
147S,-148*, A149R, L155R, G156A, T157R, A158-, A159-, V160-
, V161-, T161-, F163-, A165*, A166R,I167T, A168G, T170-,
V171-) V172-,K173-,D174-, W175-,F176-, V177-, A178R, A164S
Unknown function
SACE_6773 962 Missense (D330E) Frameshift (-G 1654) Unknown function/PE-PGRS family protein
SACE_7193 278 Frameshift (+C 729/730) Unknown function
SACE_7240 265 Missense (P90H) Unknown function
SACE_7316 47 Duplication of SACE_7316 Unknown function
aIPM, imperfect match
Figure 3 Bioreactor cultures of S. erythraea NRRL2338 and S. erythraea Px. Biomass, erythromycin production, pO2 and pH were evaluated
as described in the Materials and Methods section. Erythromycin production was monitored by HPLC. Total erythromycin is the sum of
erythromycin A, B and C. Values are means ± S.D. of three independent experiments for each strain starting from the same frozen culture.
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precursor supply for erythromycin biosynthesis. In
addition to well-established propanoate metabolism
leading to both propionyl-CoA and six (2S)-methylma-
lonyl-CoA units, alternative routes exist including
valine, leucine and isoleucine degradation pathways,
and glycine, serine and threonine metabolism. An
additional proposed route to (2S)-methylmalonyl-CoA
proceeds by the rearrangement of succinyl-CoA cata-
lyzed by methylmalonyl-CoA mutase yielding the (2R)-
isomer of methylmalonyl-CoA that would be converted
to the (2S)- isomer by a methylmalonyl-CoA
epimerase.
Our analysis demonstrated that the several genes cod-
ing for the component enzymes of the tricarboxylic acid
cycle (TCA) were mutated in Px strain. In particular,
pyc gene (SACE_6118) coding for pyruvate carboxylase
(PC) was inactivated by a frameshift mutation. This
result is noteworthy, because PC serves a major ana-
plerotic role for the TCA by catalyzing the ATP-depen-
dent carboxylation of pyruvate to oxalacetate, and there
is evidence that in Corynebacterium glutamicum PC
contributes about 90% to C(3) carboxylation at the ana-
plerotic node (Petersen, 2000). Moreover, pyc has no
obvious paralog(s) in the genome of S. erythraea. In
Figure 4 Microarray analysis showing changes in global control of cell-cycle. Visualization by dChip of 404 S. erythraea NRRL2338 and of
577 S. erythraea Px differentially expressed genes, selected by a q-value < = 0,001, and determining a time course gene expression profiling and
a hierarchical clustering of the samples (Red = up-regulation; Green = down-regulation); on the right side of the figure, two columns
respectively show the functional classification of the DEGs whose transcription profile is visualized and their positional distribution in the core
(dark blue) and non core region (light blue) of the genome.
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Table 7 Functional classification of cell cycle-regulated genes in both strainsa
Strain NRRL2338 Px
COG Functional categories % COG
probesets
% Probesets with q-value < =
0.001
% Probesets with q-value < =
0.001
I Cellular processes and signaling
I.1 Cell cycle control, cell division, chromosome
partitioning
0,35 0,99 0,69
I.2 Cell motility 0,01 0 0
I.3 Cell wall/membrane/envelope biogenesis 2,05 3,22 3,81
I.4 Defense mechanisms 0,89 0,00 0,87
I.5 Intracellular trafficking, secretion, and vesicular
transport
0,24 0,25 0,69
I.6 Posttranslational modification, protein turnover,
chaperones
1,90 5,94 3,99
I.7 Signal transduction mechanisms 1,91 0,99 1,91
II Information storage and processing
II.1 Amino acid transport and metabolism 0,01 0 0
II.2 Cell wall/membrane/envelope biogenesis 0,01 0 0
II.3 Chromatin structure and dynamics 0,01 0 0
II.4 General function prediction only 0,30 0,50 0,35
II.5 Nucleotide transport and metabolism 0,07 0 0
II.6 Posttranslational modification, protein turnover,
chaperone
0,04 0 0
II.7 Replication, recombination and repair 2,44 0,74 2,43
II.8 RNA processing and modification 0,01 0
II.9 Secondary metabolites biosynthesis, transport
catabolism
0,04 0
II.10 Signal transduction mechanisms 0,71 0,50 0,69
II.11 Transcription 7,20 2,23 3,29
II.12 Translation, ribosomal structure and biogenesis 2,48 4,21 10,75
III Metabolism
III.l Amino acid transport and metabolism 6,60 0 8,15
III.2 Carbohydrate transport and metabolism 6,08 7,67 6,59
III.3 Cell wall/membrane/envelope biogenesis 0,38 0 0,17
III.4 Coenzyme transport and metabolism 2,63 5,20 4,33
III.5 Energy production and conversion 4,79 9,90 8,15
III.6 Inorganic ion transport and metabolism 2,68 4,21 2,25
III.7 Lipid transport and metabolism 4,24 2,72 5,03
III.8 Nucleotide transport and metabolism 1,27 2,97 3,64
III.9 Posttranslational modification, protein turnover,
chaperones
0,08 0 0,17
III.10 Secondary metabolites biosynthesis, transport
catabolism
2,90 2,48 2,77
III.
11
Signal transduction mechanisms 0,16 0 0
IV Poorly characterized
IV.1 Function unknown 32,11 27,23 22,70
IV.2 General function prediction only 7,37 8,17 6,59
Total probesets 7060 404 577
aThe categories over-represented and under-represented are evidenced, respectively, by BOLD and oblique number
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addition to pyc, non-conservative missense mutations
affected both the E1 and the E2 component-encoding
genes (sucA [SACE_6385] and sucB [SACE_1638],
respectively) of the 2-oxoglutarate dehydrogenase
complex. 2- oxoglutarate dehydrogenase is a key enzyme
in the TCA cycle, converting 2-oxoglutarate, coenzyme
A and NAD(+) to succinyl-CoA, NADH and carbon
dioxide. This activity is tightly regulated and it is a
Figure 5 Visualization of the LAP algorithm results on the two chromosome strands independently analyzed. Comparison between the
transcriptional profiling of all the 6494 S. erythraea genes in phase A versus phase B in the NRRL2338 strain(A) and in the Px strain(B) is shown.
A q value of 0,01 and a fold change of 0,5 were chosen as filtering parameters. The transcriptionally up-modulated regions are shown in RED
while the down- modulated are in GREEN. The OriC is indicated as O and the resolution of the chromosome is 1 Mb. The core region is
evidenced in blue and the non-core region in orange; the position of clusters involved in the secondary metabolism, erythromycin production
and coding for ribosomal proteins are outlined by arrows.
Figure 6 Overview of carbon and nitrogen metabolic pathways and their relationships with the biosynthesis of erythromycin. Genes
affected by missense mutations are indicated in blue; genes affected by missense/nonsense mutations are shown in red. Single-copy genes are
underlined.
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major determinant of the metabolic flux through the
TCA cycle. Also in this case, obvious paralogs could not
be found in the genome of this microorganism.
Although it is difficult to predict the effect of the
observed mutations on the activity of the 2- oxogluta-
rate dehydrogenase complex, altogether our results are
consistent with the hypothesis that the carbon flux
through the TCA cycle may be greatly reduced in the
Px strain, and that, as a consequence, more acetyl-CoA
is funneled into alternative routes including propanoate
metabolism leading to the 6DEB precursors (Figure 6).
This view is supported by evidence that glutamine
synthatase/glutamate synthase (GS- GOGAT) and urea
cycles, which are linked to TCA by 2-oxoglutarate and
oxaloacetate/fumarate, respectively, may also be affected
in the Px strain. Indeed, in this strain, gltD, coding for
small subunit of glutamate synthase (SACE_5741), a
component of the high-affinity ammonium assimilation
system, is inactivated by a frameshift mutation (Table 1
and Figure 6). However, in this case, a paralogous gene
(SACE_3997) is predicted to exist in the genome, to
alleviate the deleterious effect of such a mutation. A
possible deficiency in the high-affinity ammonium
assimilation system may also account for the different
behavior of S. erythraea NRRL 2338 and Px strain with
respect to ammonium content in the growth medium.
Growth, pigment and antibiotic production was strongly
inhibited in the wild type strain in the presence of high
ammonium content, while, in contrast, the same para-
meters were not affected by ammonium in the erythro-
mycin over-producing strain (Figure 7). Frameshift
mutations inactivate SACE_6330 (argH domain) and
SACE_0635 (ureB). These CDSs may be involved in the
urea cycle as they code, respectively, for a fusion protein
with both ligase/carboxylase and argininosuccinate lyase
domains, and urease beta subunit. In the latter case, no
obvious ureB paralog could be detected in the genome.
In addition to the urea cycle, one of the two aspartate
aminotransferase-encoding paralog (aspB) (SACE_4319),
whose activity is linked to the urea cycle and is essential
for growth on L-glutamate, was also affected by a non-
conservative missense mutation.
In the absence of sulfate and cysteine, several bacteria
can use aliphatic sulfonates as a source of sulfur for
growth. tauABCD genes coding for an ABC-type trans-
port system required for uptake of aliphatic sulfonates
and a desulfonation enzyme accomplish this property.
In Px strain tauC (SACE_4434) coding for permease
component of taurine transport system, and tauD
(SACE_4651) coding for 2-oxoglutarate-dependent taur-
ine dioxygenase are affected by missense mutations,
along with cdo2 (SACE_6133) encoding a cysteine diox-
ygenase, which catalyzes the conversion of L-cysteine to
cysteine sulfinic acid, a compound that lies at a branch-
Figure 7 Effect of ammonia and phosphate on growth, pigmentation, sporulation and antibiotic production. S. erythraea NRRL 2338 and
S. erythraea Px were cultivated for 7 days on YS agar supplemented with the indicated ammonia and phosphate concentrations (left panels).
Antibiotic production in these media was evaluated by microbiological assay using Micrococcus luteus as a tester organism (right panel)
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point in cysteine catabolism, where it can follow two
pathway resulting in the formation of taurine or sulfate
(Table 1). Down-modulation or inactivation of this
metabolic pathway involving the 2-oxoglutarate-depen-
dent taurine dioxygenase may be functional to alleviate
the reduced carbon flux through the Krebs cycle by
increasing the pool of 2- oxoglutarate.
Several genes involved in nucleotide and thiamine
metabolism were also affected by non- conservative mis-
sense mutations in the Px strain, including prsA
(SACE_2398) coding for phosphoribosylpyrophosphate
(PRPP) synthase (which catalyzes the synthesis of the
common precursor for biosynthesis of histidine and pur-
ine and pyrimidine nucleotides), purF (SACE_7125) and
purH (SACE_6664) whose products code for glutamine
PRPP amidotransferase and bifunctional phosphoribosy-
laminoimidazolecarboxamide formyltransferase/IMP
cylohydrolase (which catalyzes, respectively, the first and
the second steps in the de novo biosynthesis of thiamine
and purine nucleotides), thiO (SACE_0506) and thiC
(SACE_0511) specifically involved in thiamine biosynth-
esis, and pyrC (SACE_2080) encoding dihydroorotase, a
key enzyme in pyrimidine nucleotide biosynthesis (Table
1 and Figure 6). Mutations in the above-mentioned
genes are expected to reduce the carbon flux toward
these biosynthetic pathways (purine/thiamine, pyrimi-
dine), and increase the flux toward the pentose phos-
phate (prsA mutation) and glycine, serine and threonine
metabolic pathway (purF, purH, thiO, thiC mutations).
The last pathway is a source of precursors for 6DEB
biosynthesis.
The above-mentioned genetic defects in metabolic
genes are well correlated with the slow- growth pheno-
type of the Px strain in mineral medium MM-101,
caused by nutritional requirements which are indicative
of TCA cycle precursors and PRPP limitations (Addi-
tional file 6). At the same time, our results emphasize
the balance that must be reached between pathways
competing for the same substrate to maintain robust-
ness of the metabolic network.
Secondary metabolism in S. Erythraea px
In addition to the gene clusters for erythromycin (ery),
for a second modular polyketide synthase (PKS) of
unknown function (pke) and for a type III PKS (rppA),
which generates a reddish pigment, the genome sequen-
cing of S. erythraea NRRL 2338 has revealed additional
22 clusters for the biosynthesis of polyketides, terpenes
and non-ribosomally synthesized peptides. In Px strain a
total of 19 missense/nonsense/frameshift mutations
affected genes related to biosynthesis of secondary meta-
bolites (Table 3).
Twelve of them affected genes coding for PKS or
related biosynthetic proteins. In particular, a nonsense
mutation in SACE_0019 (coding for an ACP), a frame-
shift mutation in SACE_0022 (pfaB) (coding for a mod-
ular PKS) and two non-conservative missense mutations
in SACE_0023 (pfaC) (coding for a modular PKS) inacti-
vated the pfa cluster, which appears to govern the bio-
synthesis of a polyunsaturated fatty acid such as
eicosapentaenoic acid. The pks3 cluster was inactivated
by a frameshift mutation in SACE_2875 (coding for a
modular PKS) and a non-conservative missense muta-
tions in SACE_2876 (gdmF) (coding for 3-amino-5-
hydroxybenzoic acid synthase). Missense mutations
affected the pks3-associated SACE_2888 (coding for an
aromatic-L-amino acid decarboxylase). Non-conservative
missense mutations were mapped in SACE_2630 (pks2-
1) (coding for a modular PKS) of the biosynthetic clus-
ter pks2, SACE_4140 (pkeA2) (coding for a modular
PKS) in the pke cluster, and SACE_5308 coding for a
multifunctional single- module PKS enzymes apparently
related to the iterative PKSs involved in enediyne or
methylsalicylic acid synthesis. It is conceivable that
some of these pathways may compete with that of ery-
thromycin for the same substrates and that their inacti-
vation/down-modulation may be beneficial to 6DEB
biosynthesis.
While it is difficult to predict the effects of the mis-
sense mutations affecting eryCVI and eryBVI (Table 3)
coding for the enzymes catalyzing the last steps of the
biosynthesis of dTDP-D-desosamine and dTDP-L-
mycarose biosynthesis, the activated sugars that decorate
the erythronolide B, the missense mutation affecting
SACE_6416 (rmlC) coding for dTDP-4- dehydrorham-
nose 3,5-epimerase (Table 1 and Figure 6) may cause an
increase in production of both dTDP-D-desosamine and
dTDP-L-mycarose precursors. In fact, the rmlC, eryCIV
and eryBVI gene products compete for the same sub-
strate (dTDP-4-oxo-6-deoxy-D-glucose). Additional
work is required to clarify these aspects, as well as the
possible effects of the inactivation/down-modulation of
nrps4 and nrps7 biosynthetic clusters, coding for
unknown non-ribosomally synthesized peptides, and of
tpc1/geo1 and tpc3/geo2 showing substantial similarity
to terpene cyclase-encoding clusters, which in other
microorganisms are known to produce geosmin, the ses-
quiterpene that provide the soil with its characteristic
smell.
Global and pathway-specific control of gene expression,
and DNA repair mechanisms in S. Erythraea px
Antibiotic production is under global and local pathway-
specific control. At the same time, there is evidence that
genetic manipulation of RNA polymerase and/or ribo-
some may influence the control of secondary metabo-
lism [31,32]. Mutations affecting the basic transcription
and translation machineries were thus expected in the
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erythromycin- overproducing strain (Table 4). However,
unexpectedly, several inactivating mutations mapped in
a number of genes, whose products were thought to
play fundamental roles in these processes including
nusB (SACE_2076) coding for NusB antiterminator fac-
tor and efp (SACE_2075) encoding the elongation factor
P (EF-P). Both these genes, which are organized in a
putative conserved operon also including pepQ gene
coding for Xaa-Pro dipeptidase, were inactivated by fra-
meshift mutations (Figure 8A).
NusB participates together with NusE/S10 protein in
processive transcription antitermination. NusB and
NusE, bind to form a heterodimer, which interacts with
a specific boxA site on the RNA. The NusB/NusE/boxA
RNA ternary complex interacts with the RNA polymer-
ase transcription complex, stabilizing it and allowing
transcription past premature termination points [37-40].
NusB is essential to suppress transcription termination
in the ribosomal RNA (rrn) operons. Compared to wild
type Escherichia coli, about two-fold decreased RNA
polymerase density was observed by electron microscopy
over 23S genes in a nusB mutant [41]. As a conse-
quence, the fraction of total RNA polymerase engaged
in transcribing the rrn operons is significantly reduced
in a nusB mutant. Similar reduction is observed during
the stringent response, when (p)ppGpp binds RNA poly-
merase and changes the global transcriptional profile,
decreasing the synthesis of translational machinery and
increasing the transcription of biosynthetic genes includ-
ing those coding for antibiotics in actinomycetes
[32,42-48].
EF-P is a highly conserved protein that is essential for
protein synthesis in several bacteria including E. coli
[49]. It has been suggested that EF-P plays a role in
translational fidelity, prevents entry of fMet-tRNA into
the A-site enabling it to bind to the 50S P-site, and pro-
motes a ribosome-dependent accommodation of fMet-
tRNA into the 70S P-site [50,51]. In Bacillus subtilis
genetic inactivation of EF-P abolished spore formation
without affecting growth [52]. Although it is difficult to
predict the effects of EF-P inactivation on erythromycin
production, it is relevant to note that erythromycin pro-
duction in S. erythraea is stimulated by streptomycin-
resistance mutations [31] and that EF-P was shown to
protect 16S rRNA near the G526 streptomycin and the
S12 and mRNA binding sites (30S T-site) [50].
In addition to EF-P, other genetic changes occurs in
the Px strains affecting the translational machinery,
including missense mutations affecting SACE_5926
(infB) coding for the translation initiation factor 2,
(SACE_0799) (metS) coding form methionyl-tRNA
synthetase, SACE_0443 (cysS paralog) encoding a cystei-
nyl-tRNA synthatase, SACE_3403 (gatA) coding for A
subunit of Asp-tRNA Asn/Glu-tRNA Gln amidotrans-
ferase, and a frameshift mutation inactivating a paralo-
gous gene (SACE_5919) coding for pseudouridine
synthase. These findings emphasize the importance of
the translational machinery as a potential target for
improvement of antibiotic-producing strains.
The mutations affecting the basic transcription and
translation machineries may in turn affect pathway-spe-
cific control accounting for the global changes in tran-
scriptional profile, which was observed in Px strain with
respect to NRRL 2338 (Figures 4 and 5). As previously
mentioned, a total of 459 and 220 genes were up-regu-
lated during growth phase a in Px and in NRRL 2338
respectively. Among these DEGs, 138 were up-regulated
in both strains, while 335 and 114 were specific for Px
Figure 8 Expression of bldD during growth of S. erythraea NRRL 2338 and S. erythraea Px. A) Genetic map of the chromosomal region
spanning the pepQ-efp-nusB and bldD genes. B) bldD mRNA levels are expressed as average of log ratio normalized microarray duplicate data
(RMA). bldD expression values from S. erythraea NRRL 2338 and S. erythraea Px do not vary more than 1.58% and 2.61%, respectively, on the
average.
Peano et al. Microbial Cell Factories 2012, 11:32
http://www.microbialcellfactories.com/content/11/1/32
Page 19 of 25
and NRRL 2338, respectively (Additional file 3, 4, 5).
Within the list of genes specifically up-regulated in the
Px strain, we found most of the genes belonging to the
ery biosynthetic gene cluster. Regulation of the ery clus-
ter was found to be altered also in another classically
improved S. erythraea strain, which exhibited prolonged
expression of antibiotic biosynthetic genes compared to
the wild type during fermentation [34].
In addition to the ery cluster, SACE_1456 (mmsA2)
coding for methylmalonate semialdehyde dehydrogenase
was also found to be up-regulated in Px. This enzyme
provides 6DEB biosynthesis with propionyl-CoA and
(2S)-methylmalonyl-CoA precursors (Figure 6) and was
found to be up-regulated in a rifampicin-resistant ery-
thromycin-overproducing mutant of S. erythraea [32].
Moreover, the expression of bldD (SACE_2077), coding
for a key developmental regulator that seems to regulate
the ery cluster positively, was also up- regulated during
phase a in the Px strain (Figure 8B). Intriguingly, this
gene maps immediately downstream of the pepQ-efp-
nusB locus in the genome of S. erythraea (Figure 8A).
In addition to the ery cluster and associated CDSs, the
genes belonging to the pks6 and tpc5 (geo3) biosynthetic
clusters were also found to be up-regulated in this strain
along with nusA (SACE_5927 coding for transcriptional
termination/antitermination factor NusA), ribosomal
protein operons with the associated genes infA
(SACE_6808 coding for translation initiation factor IF1),
tufA (SACE_6838 coding for elongation factor EF1A),
fusA (SACE_6839 coding for translation elongation fac-
tor G), and F0F1 ATPase. In contrast, in the list of
genes specifically up-regulated in the NRRL 2338, we
found many genes related to the TCA cycle including
fumB (SACE_1784 coding for class I fumarate hydra-
tase), fumC (SACE_0930 coding for class I fumarate
hydratase), korA (SACE_3927 coding for 2- oxalogluta-
rate ferredoxin oxidoreductase alpha subunit), the urea
cycle (ureA) (SACE_0634 coding for urease gamma sub-
unit) or the PRPP biosynthesis (prsA) (SACE_0816).
In addition to changes in basic transcription and
translation machineries, mutations in genes coding for
transcriptional factors and signal transduction proteins
may contribute to alter pathway-specific control. In par-
ticular, 13 genes coding for transcriptional factors and 5
genes encoding two-component system proteins were
affected by missense or frameshift mutations in Px
(Table 4). However, in the absence of functional data,
the effects of such mutations on secondary metabolism
may be only hypothesized on the basis of proximity of
the mutated regulatory genes to the biosynthetic cluster
for secondary metabolites. For instance, SACE_3079,
coding for a LysR family transcriptional regulator and
affected by a frame shift mutation in the same strain, is
genetically linked to a hydrogenase operon (also
containing gmhA genes, which were shown to be inacti-
vated by frameshift mutations in Px) and may be
involved in its regulation. Similarly, SACE_4500, encod-
ing a GntR family transcriptional regulator that is inacti-
vated by a frameshift mutation in Px, maps close to
sarcosine oxidase operon. Sarcosine oxidase links glycer-
ophospholipid metabolism to erythromycin biosynthesis
catalyzing the oxidative demethylation of sarcosine to
glycine, whose metabolism provides the biosynthesis of
6DEB with precursors (Figure 6).
Px strain was obtained by multiple cycle of mutagen-
esis by chemical (N-methyl-N-nitro-N- nitrosoguani-
dine) or radiation (X-ray and UV) agents. The sequence
data suggests that the mutagenesis/selection process to
erythromycin-overproduction phenotype might have
been accelerated by selection of mutator phenotype.
This hypothesis is supported by missense and frameshift
mutations affecting genes involved in DNA replication
and repair. In particular, SACE_0826 (mfd) coding for
transcription/repair coupling factor, SACE_4427 (mug)
coding for G/U mismatch-specific DNA glycosidase and
SACE_5437 (polA) were inactivated by frameshift muta-
tions, while missense mutations affected other genes
involved in these processes (Table 5).
Conclusions
Overall our findings demonstrate that the phenotypes of
the erythromycin-overproducing strain S. erythraea Px
are associated with a large number of genetic changes
with respect to the reference strain NRRL 2338. Muta-
tions affect 227 CDSs, corresponding to about 3% of
CDSs of S. erythraea genome. Although certain muta-
tions may be neutral in term of improved antibiotic pro-
duction, and may have been favored by the mutator
background of Px, a considerable number of them map
within genes coding for key enzymes involved in central
carbon and nitrogen metabolism, and biosynthesis of
secondary metabolites, redirecting common precursors
toward erythromycin biosynthesis. Several mutations
inactivate genes coding for proteins that play fundamen-
tal roles in basic transcription and translation machi-
neries including the transcription anti-termination factor
NusB and the transcription elongation factor Efp, and
genes coding for pleiotropic or pathway-specific regula-
tors, with dramatic effects on global expression profile.
The comparison of Px and NRRL 2338 at both genomic
and transcriptomic levels not only contributed to eluci-
date the molecular mechanism underlying the overpro-
duction of erythromycin, but also revealed new possible
targets suitable for rationale improvement of industrial
antibiotic-producing strains. However, as most of
mutated genes are not directly related to the erythomy-
cin over- production, next effort will be to test the gen-
ome-assisted predictions by experimental verification.
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Methods
Bacterial strains and media
S. erythraea wild type strain NRRL2338 was a gift of S.
Donadio (KtedoGen, Milan, Italy). This strain has been
deposited at the American Type Culture Collection. S. ery-
thraea Px is an erythromycin-overproducing strain that
was obtained by the traditional mutate-and-screen method
over a period of about 10 years. The strains were stored in
1-ml cryotubes at -80°C as frozen mycelium in YS med-
ium containing 15% glycerol at a biomass concentration of
approximately 0.25 g dry cell weight (DCW) ml-1, or at
-20°C as spores in 20% glycerol (in distilled water) at a
title of approximately 5 × 108 ml-1. The composition (per
liter) of the complete media used in this study is reported
in Table 8. When requested all media were agarized at a
concentration of 1.8%. The composition (per liter) of the
nutrient broth agar in the microbiological assays with
Micrococcus luteus tester strain was: 3 g beef extract, 5 g
tryptone, 15 g NaCl, 15 g agar.
Preparation of spores
Concentrated spore suspensions (5 × 108 ml-1) are crucial
for purposes like starting reproducible cultures for physio-
logical or fermentation studies. To prepare spores adapted
to the conditions of liquid medium, spores were spread on
the same medium with agar. Mycelium with spores was
strongly attached to the surface agar, thus making impos-
sible to collect spores without agar traces. Therefore,
strains have been grown on cellophane discs, as described
in [53]. The cellophane discs were sterilized in distilled
water and then placed on agar, and the inoculum was
spread on cellophane using a glass stick. After two weeks,
spores (control in microscope) were easily scraped from
cellophane and stored in 20% glycerol at - 20°C.
Growth conditions
For shake-flask experiments, spores in frozen aliquots
were collected by centrifugation, re- suspended in
medium 707 (for rehydration), and readily separated by
vortexing. Individual aliquots (about 5 × 108 spores)
were used to inoculate each 500 ml baffled Erlenmeyer
flask containing 50 ml of the liquid media described
above. Cultures were incubated at 30°C with shaking at
250 rpm. Bioreactor cultures were carried out on Mini-
fors mini-fermenters (Infors AG, Bottmingen, CH) that
operated with a working volume of 1.5 l. Stirring was
provided by Rushton-type impellors rotating at 250 rpm.
Sterile air was supplied through a sparger. The bioreac-
tors were equipped with pH electrode, pO2 electrode
(polarographic), antifoam probe and Pt-100.
Erythromycin assays
Erythromycin production in solid media was assayed by
bioassay. To this purpose, S. erythraea strains were
grown in solid media (30 ml) in Petri dishes (8.5 cm).
After desired time of cultivation, agar discs of 1.6 cm in
diameter (with mycelium on the surface) were removed
and placed into empty Petri dishes (diameter 8.5 cm).
Petri dishes were then filled with soft nutrient agar
seeded with Micrococcus luteus. Diameters of the zone
of inhibition were measured after 2 days of incubation
at 37°C. Agar discs containing defined amounts of >
95% pure erythromycin A (Sigma) were used as a refer-
ence. In liquid media, erythromycin was extracted as
described [54]. Five hundred μL of n-butylacetate were
added to 500 μL of broth fermentation, samples were
vortexed for 5 min and centrifuged at 9500 g for 15
min. Then the organic phase was mixed with 500 μL
buffer 25 mM K2PO4 pH 5 and centrifuged at 800 g for
5 min. Ten μL of the aqueous phase was injected into
HPLC.
HPLC analyses were carried out using an Agilent 1100
Series HPLC system equipped with security guard Car-
tridges (C18 ODS 4×3 mm) and a Phenomenex-luna 5
μC18 (2) 100 Å column (250×4.6 mm). An isocratic elu-
tion mode was used according to [55] Tsuji and Goetz
Table 8 Composition of the media used in this study
Medium Composition (per liter) pH
Complex
Seed medium (SM) 4 g peptone, 4 g yeast extract, 2 g KH2PO4, 4 g K2HPO4, 0.5 g MgSO47H20, 10 g glucose 7.2
Yeast starch (YS) 2 g yeast extract, 10 g soluble starch 7.3
Oat meal yeast (OMY) 40 g oatmeal, 1 g yeast extract 6.8-
7.0
Soluble complete medium
(SCM)
20 g soytone, 15 g soluble starch, 10.5 g morpholinepropanesulfonic acid, 1.5 g yeast extract, 0.1 g CaCl2 7.2
Chemically defined
MM-101 7 g NH4Cl, 3 g KH2PO4, 7 g K2HPO4, 0.25 g MgSO4 • 7 H2O, 0.0138 g CaCl2 • 2 H2O, 10 g glucose, 2 ml trace
solution element (TSE)a
6.9
aWhen indicated 1.0 g casamino acids (Difco, Detroit, Mich.) and/or 2 ml (per liter) trace solution element (TSE) were added. The TSE solution composition (per
liter) was: 40 mg ZnCl2, 200 mg FeCl3 • 6 H2O, 10 mg CuCl2 • 2 H2O, 10 mg MnCl2 • 4 H2O, 10 mg Na2B4O7 • 10 H2O, 10 mg (NH4)6Mo7O24 • 4 H2O
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(1978). Mobile phase was as follows: acetonitrile-metha-
nol-0.2 M ammonium acetate-water (45:10:10:35) at pH
7.8, at flow rate of 1 ml min-1 at 25°C using UV detector
at 215 nm. Quantification of the erythromycin was
achieved using calibration curves of peak area against
injected concentration of the various erythromycin stan-
dards A, B, C (European Pharmacopoeia HPLC assay).
DNA procedures
High molecular weight genomic DNA was extracted
from S. erythraea strains grown in 50 ml of SM medium
with shaking at 28°C for 5 days (120 h). After centrifu-
gation, the mycelium was re-suspended in 10 ml SET
buffer (75 mM NaCl, 25 mM EDTA, 20 mM Tris- Cl
pH 7.5) and incubated in the presence of 5 mg ml-1
lysozyme for 30’ at 37°C. Samples were sonicated (Soni-
fer sonicator Model 250/240, Brain Ultrasonic Corpora-
tion) 3 times for 30 sec, and incubated in the presence
of 20 mg ml-1 Proteinase K and 1.2% sodium dodecyl
sulfate (SDS) for 2 h at 55°C. Nucleic acids were
extracted by fenol-chloroform:isoamylic alcohol (24:1)
according to standard procedure (Sambrook and Russell,
2001) and RNA removed using 15 μg ml-1 ribonuclease
A. After fenol-chloroform:isoamylic alcohol (24:1)
extraction and ethanol-precipitation, high molecular-
weight DNA was collected by spooling using Shepherd’s
crooks [56,57].
Sequencing and assembly of the S. Erythraea px genome
Whole-genome shotgun DNA sequencing of S. ery-
thraea Px genome was performed by MWG Biotech
(Eurofins MWG Operon, Ebersberg, Germany) using
frequently cutting restriction enzymes and 2- to 10-kbp
fragments cloned into plasmid vectors. Cosmids (32-46
kbp inserts) were also generated from genomic DNA
and end-sequenced to provide additional read-pair infor-
mation, increase coverage of selected regions, and fill
the gaps. Remaining gaps and ambiguities were closed
using PCR products from specifically designed oligonu-
cleotide primers. Sequence assembly was done using the
Phrap assembler43 and editing was done using consed
version 14. Repeats were resolved by doing a mini-
assembly for the individual sections of the genome and
the resulting consensus was integrated into the main
genome assembly.
RNA extraction and RNA microarray experiments
The S. erythraea Custom GeneChip used for the
NRRL2338 strain gene expression profiling by Peano et
al. [24] was used here to analyze the time course gene
expression profiling of the Px strain. The sequences of
all probes present on the GeneChip were compared
with the genomic sequence of the Px strain using
BLASTN [58], finding a perfect match for all of them,
both for similarity (100%) and length (25 bp).
For each time point, RNA was extracted from myce-
lium pellets deriving from 1-ml culture samples using
the GeneElute™ total RNA Purification Kit (SIGMA),
recovering it in 50 μl of Elution Solution. After extrac-
tion RNAs were quantified with a NanoDrop spectro-
photometer (NanoDrop Technologies) and analyzed by
capillary electrophoresis on a Agilent Bioanalyzer (Agi-
lent). The RNA samples showing an RIN (RNA Integrity
Number, a quality parameter calculated by the instru-
ment software) value higher than 7 were processed for
microarray hybridization, following the instructions for
“Prokaryotic Target Preparation” (Affymetrix GeneChip®
Expression Analysis Technical Manual). The protocol
consists in cDNA synthesis by reverse transcription
(starting with 10 μg RNA), followed by cDNA fragmen-
tation with DNase I and labeling with Terminal Deoxy-
nucleotidyl Transferase. The labeled cDNAs were then
hybridized for 16 h at 50°C on individual GeneChips.
After hybridization, GeneChips were washed and stained
with streptavidin-conjugated phycoerythrin by using the
Fluidic Station FS450 (Affymetrix) following the
FS450_0005 Protocol. Fluorescent images of the micro-
arrays were acquired using a GeneChip Scanner 3000
(Affymetrix). All raw data files are available in Gene
Expression Omnibus under accession number
GSE30600.
Genomic comparison and variation detection
The software Nucmer from the MUMmer package [59]
(http://mummer.sourceforge.net) was used to investigate
the presence of possibly large genomic rearrangement.
All other comparative analyses have been carried out
using the BLAST suite from NCBI (http://www.ncbi.
nlm.nih.gov/BLAST,ftp://ftp.ncbi.nih.gov/blast), in parti-
cular the BLASTx and BLASTn programs, whose results
were then parsed using home-made scripts. The circular
plots were generated by an home-made Python script.
The sequences of the 227 genes (SACX_) affected by
mutations in the Px strain as compared to correspond-
ing genes (SACE_) in the parental NRRL2338 strain
have been submitted to GeneBank (accession numbers:
from JN392509 to JN392716 in Additional file 7).
Microarray data analysis
The quality of the raw data obtained from microarray
hybridization was assessed considering the MAS5.0
(Microarray Suite/Software, Affymetrix) control para-
meters after a global scaling at a target intensity of 100.
Quality and control parameters as well as box plots of
raw intensities highlighted the overall high quality of the
data set and the absence of any outlying sample. Probe
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level data was converted to expression values using both
the Robust Multi- array Average (RMA) procedure [60]
and the MAS5.0 algorithms. In the former case, PM
values (Perfect Match) were background-adjusted, nor-
malized using invariant set normalization, and log trans-
formed. In the latter case, intensity levels were
normalized using the Global Scaling option to target
value (i.e. TGT = 100).
Genes characterized by a statistically significant modu-
lation of the expression level during the growth time
course (within-class temporal differential expression)
were identified using the EDGE software package, which
is based on the Optimal Discovery Procedure [61] and
allows identifying genes that are differentially expressed
between two or more different biological conditions or
to perform significance analysis on time course experi-
ments [62]. Whereas other methods employ statistics
essentially designed for testing one gene at a time (e.g.
t-statistics and F-statistics), the ODP uses all relevant
information from all genes to test each gene for differ-
ential expression, thus improving the power of the test.
In the particular case of a time course, ODP takes into
account the ordering and spacing information provided
by the time points.
Briefly, we have tested each gene by first fitting a
model (e.g. natural cubic sp-lines) under the null
hypothesis that there is no differential expression, and
then under the alternative hypothesis that there is differ-
ential expression. A statistic is calculated to compare the
goodness of fit of the two models under the two differ-
ent hypotheses. The statistic is a quantification of evi-
dence for transcriptional modulation, and the larger it is
the more differentially expressed the gene appears to be.
Once the statistic is calculated for each gene, a signifi-
cance cut-off is applied using a false discovery rate cri-
terion. This process, based on the calculation of the null
distribution of the statistics when there is no differential
expression, is accomplished through a data re-sampling
technique and results in the q-value. Modulated genes
are finally selected based on the q-value threshold and,
eventually on a fold change limit. Differentially
expressed genes were selected considering each time
point replicate as an independent entry and setting the
confidence threshold at q-value ≤ 0.001. Hierarchical
clustering and Eisen’s maps were used to group modu-
lated genes and samples in the software package dChip.
Before clustering, the expression values for a gene across
all samples were standardized (linearly scaled) to have
mean 0 and standard deviation 1, and these standar-
dized values were used to calculated correlations
between genes and samples and served as the basis for
merging nodes. Hierarchical agglomerative clustering
was carried out using Pearson correlation coefficient as
distance metric and centroid as linkage method.
Chromosomal regions presenting a between-class tem-
poral differential expression were identified using
PREDA [35,63,64]. PREDA is a bioinformatic tool devel-
oped under R statistical environment for the identifica-
tion of differentially expressed chromosomal regions,
which accounts for variations in gene distance and den-
sity. PREDA consists of three main steps: i) computation
of a statistic for ranking probes in order of strength of
evidence for an expression feature; ii) adaptive band-
width smoothing of the statistic after sorting the statisti-
cal scores according to the chromosomal position of the
corresponding genes; and iii) application of a permuta-
tion test to identify differentially expressed chromoso-
mal regions with a q-value correction for multiple tests.
Transcriptional and structural information are locally
integrated smoothing, along the chromosomal coordi-
nate, an expression statistic. The smoothing procedure
is approached as a non-parametric regression problem
using a local variable bandwidth kernel estimator. A
permutation scheme is used to identify differentially
expressed regions under the assumption that each gene
has a unique neighborhood and that the corresponding
smoothed statistic is not comparable with any statistic
smoothed in other regions of the genome. The permuta-
tion process over B random assignments allows defining
a null smoothed statistic for any chromosomal position.
The significance of the differentially expressed regions
(i.e. the p-value) is computed as the probability that the
random null statistic exceeds the observed statistic over
B permutations. Once the distribution of empirical p-
values has been generated, the q-value is used to identify
differentially expressed chromosomal regions according
to Storey and Tibshirani [65].
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